397.70999 USD
0.367
0.09%
Last update Dec 16, 3:33 PM GMT
Main market
Day range
390.67990
397.70999
Previous close
397.34299
Open
390.67990
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
397.71
0.37
0.09%

Financials

Cash flow

Fundamentals currency is IDR
Fiscal date Sep 2022 Jun 2022 Mar 2022 Dec 2021
Operating activities
Net income
Depreciation
Deferred taxes
StockBased compensation
Other non cash items
Accounts receivable
Accounts payable
Other assets liabilities
Investing activities -325.0B 252.1B -45.5B -8.8B
Capital expenditures -63.8B -34.4B -44.7B -5.6B
Net intangibles
Net acquisitions -67.2B 285.0B 0 0
Purchase of investments -199.1B
Sale of investments 563.3M
Other investing activity 5.2B 1.5B -1.3B -3.2B
Financing activities 0 0 -50B -9.6B
Long term debt issuance 0 -59.0B
Long term debt payments 0 0 -50B 49.4B
Short term debt issuance
Common stock issuance
Common stock repurchase
Common dividends
Other financing charges
End cash position 7.9T 7.7T 7.0T 6.4T
Income tax paid
Interest paid
Free cash flow 346.5B 425.1B 684.3B 706.8B
Access the full /cash_flow historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 6 hours 45 minutes

09:44
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).